Ipamorelin activates the ghrelin receptor (GHS-R1a), triggering discrete GH pulses similar to the natural episodic release pattern
You'll see cravings return, diabetics can see blood sugar spike and your weight loss will likely plateau
(Study: Buse et al., 2018) Clinical Applications: It can be effectively utilized alongside other weight management medications and may be particularly beneficial for individuals managing both obesity and type 2 diabetes
Notably, this combination exerts additive or synergistic actions by targeting distinct neuroendocrine pathways: cagrilintide modulates homeostatic and hedonic food regulation centers in the hindbrain and hypothalamus, while semaglutide engages central and peripheral GLP-1 pathways to reduce calorie intake and improve glycemic regulation
2 and 3 are provided in Supplementary Data 23 and 24, respectively
Consult a licensed healthcare provider before starting, stopping, or adjusting any medication